Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
How to create Custom Rest Resources for POST methods in Drupal 8
One of the biggest changes in Drupal 8 is the integration of Rest services in the core. With use of Views it become very easy to create RESTful Services. But there are certain situations when you…
|
Boost your Drupal development with Docker
Vagrant is a great virtualisation tool, which I prefer heavily for my development purposes. But sometimes it gets a bit hectic and resource consuming, to set up a new vagrant environment to work…
|
How to define your own Services in Drupal 8
Service is a PHP class with some code that provides a single specific functionality throughout the application. So you can easily access each service and use its functionality wherever you need it.…
The Global Training Day, Bangalore
April 9 was a day filled with enthusiasm as we set forth with “The Drupal Global Day training” here at Valuebound. With a crowd of over 20 people and 5 trainers the knowledge sharing session…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
